
A public workshop held by the FDA examined how social media and mobile health may inform medical product safety and efficacy.
A public workshop held by the FDA examined how social media and mobile health may inform medical product safety and efficacy.
Experimental tyrosine kinase inhibitor targets T790M mutation-positive non-small cell lung cancer.
Use of these hepatoprotective agents may reduce the risk of liver damage caused by ingredients in Technivie and Viekira Pak.
Colon cancer in African Americans associated with more aggressive clinical behavior.
Researchers find link between HIV infection and stroke.
Collaboration between caregivers vital to accurately diagnose precursor lesions in inflammatory bowel disease.
Research may offer hope for hepatitis C patients with liver disease.
The FDA has approved insulin glargine injection, a long-acting human insulin analog to improve glycemic control among adult and pediatric patients with type 1 diabetes and adults with type 2 diabetes.
Insurance coverage and use of care improves among minorities following reform.
Michael Zeglinski, vice president of Specialty Pharmacy Operations at BriovaRx, discusses how specialty pharmacies can help patients manage increasing copay costs.
An overview of Daklinza (daclatasvir) for pharmacists.
Long chain fatty acids found to promote the development and propagation of inflammatory cells.
A new report by the Berkeley Research Group provides numbers on Medicare Part B spending by 340B entities, especially for oncology drugs.
The FDA has approved sugammadex (Bridion) to reverse the effects of neuromuscular blockade created by rocuronium bromide and vercuronium bromide.
Panel suggests different regimens for different hepatitis C patient groups.
Pharmacists continue to rank among the most honest and ethical professionals in America, according to Gallup's latest poll on the topic.
Pharmacists in Minnesota are fighting for the rights to take breaks and refuse to work more than 12 hours in a row.
New treatments for HIV infection are desperately needed.
There may be several different disorders within Crohn's disease and ulcerative colitis.
Latest developments in oncology drug research.
Hope on the horizon for patients with liver damage.
Researchers seek a better understanding of the mechanism behind hepatocellular carcinoma.
Four specific gut bacteria protect babies from developing asthma.
Revenue not expected to maintain pace of current immunology treatments.
Catch up with the most read articles of the week on Specialty Pharmacy Times.
Democrats and Republicans agreeing on something having to do with the Affordable Care Act is unusual, but there is one aspect of the health care law that both parties feel the same about: the excise, or Cadillac, tax.
New research may allow for HIV to be attacked at its core.
Researchers evaluate link between hemoglobin and morbidity in patients who undergo major gastrointestinal surgery.
Diabetes is a known risk factor for cognitive decline and dementia.